Author:
Correa D .D.,Wang Y.,West J .D.,Peck K .K.,Root J .C.,Baser R .E.,Thaler H .T.,Shore T .B.,Jakubowski A.,Saykin A .J.,Relkin N.
Publisher
Springer Science and Business Media LLC
Subject
Behavioral Neuroscience,Psychiatry and Mental health,Cellular and Molecular Neuroscience,Clinical Neurology,Cognitive Neuroscience,Neurology,Radiology Nuclear Medicine and imaging
Reference62 articles.
1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192–201.
2. Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer-and cancer treatment–associated cognitive change: an update on the state of the science. Journal of Clinical Oncology, 30, 3675–3686.
3. Andrykowski, M. A., Schmitt, F. A., Gregg, M. E., Brady, M. J., Lamb, D. G., & Henslee-Downey, P. J. (1992). Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer, 70, 2288–2297.
4. Bartynski, W. S., Zeigler, Z., Spearman, M. P., Lin, L., Shadduck, R. K., & Lister, J. (2001). Etiology of cortical and white matter lesions in cyclosporin-a and FK-506 neurotoxicity. American Journal of Neuroradiology, 22, 1901–1914.
5. Basser, P. J., & Pierpaoli, C. (2011). Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. Journal of Magnetic Resonance, 213, 560–570.